PTSD as an Injury: How Neuroplasticity Is Changing Trauma Treatment
Post-traumatic stress disorder is often discussed as a mental health disorder, but that language can obscure what trauma actually does. PTSD is not a weakness, a failure to “move on,” or simply a collection of distressing thoughts. Trauma can produce lasting biological changes in the brain and nervous system, affecting threat detection, memory, sleep, emotional regulation, attention, and the body’s stress response. For this reason, some clinicians, veterans, first responders, and advocates use the term post-traumatic stress injury, or PTSI—shifting the question from “What is wrong with you?” to “What happened to you, what was affected, and what may help you heal?”
NPA Quick Read
|
Why Call PTSD an Injury?
Psychiatrist Dr. Frank Ochberg, one of the early leaders in PTSD research and treatment, has advocated replacing the word “disorder” with “injury.”
His argument is not that PTSD and a physical brain injury are the same. Rather, the injury framework recognizes that a person may have been functioning before trauma and then experienced an event—or repeated events—that produced lasting psychological, neurological, and physiological consequences.
For many people, the word disorder feels as though something is inherently wrong with them. The word injury places the emphasis on what happened and reinforces the possibility of treatment, adaptation, and recovery.
This language has been particularly meaningful to veterans, military personnel, first responders, journalists, survivors of violence, and others exposed to trauma through their work or lived experiences.
However, PTSI is not currently a formal diagnosis in the Diagnostic and Statistical Manual of Mental Disorders or the International Classification of Diseases. PTSD remains the term used for diagnosis, insurance, research, and access to many services.
The most accurate approach is to understand PTSI as an injury-informed framework for PTSD—not as another name for traumatic brain injury.
PTSD, PTSI, and TBI Are Not the Same
These terms are related, but they should not be used interchangeably.
PTSD
Post-traumatic stress disorder is a formally recognized trauma- and stressor-related condition. It may develop after someone experiences or witnesses actual or threatened death, serious injury, sexual violence, combat, assault, disaster, or another traumatic event.
Symptoms may include:
Intrusive memories or flashbacks
Trauma-related nightmares
Avoidance of reminders
Hypervigilance
Feeling detached or emotionally numb
Negative changes in beliefs or mood
Irritability and exaggerated startle responses
Difficulty concentrating or sleeping
PTSI
Post-traumatic stress injury is a nonclinical term that emphasizes the harm caused by trauma and seeks to reduce the stigma associated with being described as “disordered.”
It may be used broadly to describe trauma-related psychological injuries, including PTSD and other conditions that interfere with work, relationships, health, or daily functioning.
TBI
A traumatic brain injury results from an external physical force—such as a blow, jolt, fall, collision, blast, or penetrating injury—that disrupts brain function.
Someone can experience:
PTSD without a TBI
A TBI without PTSD
Both PTSD and a TBI following the same or different events
This distinction matters because the evaluation and treatment plan may be different. At the same time, care should be coordinated when the two conditions occur together.
What Can Trauma Change in the Brain?
The brain is designed to learn from danger. During a traumatic event, survival systems mobilize quickly. Attention narrows. The body prepares to fight, flee, freeze, submit, or seek protection. Stress hormones and autonomic responses help the person respond to an immediate threat.
After the danger has passed, these systems usually begin returning toward baseline. In PTSD, aspects of the survival response may continue operating as though danger remains present. Research has identified changes involving several interconnected systems.
The amygdala and threat detection
The amygdala helps detect emotionally significant information, including potential danger. In PTSD, threat-related circuits may become highly reactive, causing neutral or ambiguous situations to trigger an intense alarm response.
The hippocampus and context
The hippocampus helps organize memory and distinguish one context from another. Difficulties with contextual processing may contribute to the sense that a past threat is happening again in the present.
A smell, sound, location, facial expression, or bodily sensation may activate a trauma response before the person consciously understands why.
The prefrontal cortex and regulation
Prefrontal brain regions contribute to planning, attention, emotional regulation, decision-making, and the ability to evaluate whether a threat is current.
When survival circuits dominate, the brain may have more difficulty using these regulatory processes to quiet an alarm response.
The salience, attention, and default-mode networks
PTSD is also associated with altered communication among larger brain networks involved in identifying what matters, directing attention, regulating emotion, processing internal experience, and maintaining a coherent sense of self.
The nervous system and the body
PTSD is not limited to the brain. It can involve changes in sleep, heart rate, muscle tension, pain, digestion, immune activity, stress hormones, and autonomic regulation.
This helps explain why someone may intellectually know that they are safe while their body continues responding as though the traumatic event is still happening.
Current research describes PTSD through changes in fear learning, neurocircuitry, molecular signaling, genomic influences, memory, and stress physiology. These are real biological processes, even though they are not identical in every person with PTSD.
Trauma Uses Neuroplasticity—and So Does Recovery
Neuroplasticity is the nervous system’s ability to change its activity, connections, and organization in response to experience.
Trauma can use plasticity in an unhelpful way. The brain learns associations between danger and particular sights, sounds, thoughts, sensations, or environments. Avoidance can then reinforce the brain’s expectation that those reminders remain unsafe. But neuroplasticity is not only part of how PTSD develops. It is also part of how recovery becomes possible.
A 2025 scientific review found that traumatic experiences can affect synaptic and myelin plasticity within circuits involving the amygdala, hippocampus, and prefrontal cortex. The same plastic processes may also contribute to prevention and positive treatment outcomes.
Effective treatment may help the brain learn that:
The traumatic event happened in the past
A reminder is not the same as the original danger
Distressing memories can be approached without being overwhelmed
Avoidance is not the only route to safety
Emotional and bodily responses can rise and then fall
The person can regain choice, connection, and participation in life
Recovery does not require erasing the memory. The goal is to help the memory become something that is remembered rather than repeatedly relived.
Established Treatments That Support Change
A treatment does not have to be marketed as “brain rewiring” to use neuroplasticity. Evidence-based psychotherapies rely on learning, repetition, memory processing, emotional regulation, and corrective experiences.
The current VA/DoD clinical guideline recommends individual trauma-focused psychotherapy over medication when an appropriate therapy is available and acceptable to the person.
The three therapies with the strongest recommendations are:
Cognitive Processing Therapy
Cognitive Processing Therapy, or CPT, helps people identify and examine beliefs that developed after trauma.
Someone may believe:
“I should have prevented it.”
“No one can be trusted.”
“I am permanently damaged.”
“The world is never safe.”
“What happened was my fault.”
CPT does not ask someone to replace painful realities with forced positive thinking. It helps them evaluate whether trauma has created rigid beliefs that continue shaping their life long after the event.
Prolonged Exposure
Prolonged Exposure, or PE, helps a person gradually approach trauma memories and safe situations they have been avoiding. Through structured repetition, the brain can learn that remembering the trauma is not the same as being back inside it—and that some avoided environments or activities are not currently dangerous.
EMDR
Eye Movement Desensitization and Reprocessing, or EMDR, involves recalling aspects of a traumatic experience while engaging in bilateral stimulation, such as guided eye movements.
Research supports EMDR as a trauma-focused PTSD treatment, although scientists continue studying its exact mechanisms.
Medication
Medications may also be appropriate. The VA/DoD guideline recommends sertraline, paroxetine, or venlafaxine as medication options for PTSD.
Medication decisions should consider symptoms, medical history, side effects, other medications, personal preferences, and access to psychotherapy. Medication may reduce symptoms enough to help someone sleep, function, or participate more fully in treatment.
These established approaches should remain the foundation of an article about innovation. New technology should not be presented as automatically superior to treatments with decades of evidence.
How Is PTSD Treatment Changing?
Researchers are now moving toward more personalized treatment based on the person’s symptoms, brain-network patterns, biology, preferences, and response to earlier care.
Some innovations are already available in limited settings. Others remain experimental.
Personalized Brain Stimulation
Transcranial magnetic stimulation, or TMS, uses magnetic pulses to influence activity in targeted areas of the brain without surgery.
Researchers are studying whether TMS can help regulate networks involved in threat processing, attention, mood, and emotional regulation.
A 2026 randomized trial tested personalized TMS targets selected using each participant’s functional brain connectivity. Active treatment reduced amygdala threat reactivity, and longer-term follow-up showed improvements in hyperarousal and total PTSD symptoms compared with sham treatment. The findings are promising, but the study was relatively small and does not establish one universal PTSD protocol.
A separate VA analysis of 756 veterans with both PTSD and depression reported improvement following several forms of magnetic stimulation. More research is needed to determine which protocols work best, who is most likely to benefit, and how TMS should be combined with psychotherapy.
Researchers are also studying:
Intermittent theta-burst stimulation
Transcranial direct-current stimulation
Transcutaneous vagus-nerve stimulation
Accelerated treatment schedules
Imaging-guided treatment targets
Remote or home-supported stimulation
These approaches should be described as emerging unless a particular device and use have received regulatory authorization.
Electrical Vestibular Stimulation
In 2026, the FDA granted De Novo authorization to a prescription home-use device designed to treat symptoms associated with PTSD in adults. The device delivers small electrical pulses behind the ear to stimulate the vestibular system and influence deeper networks involved in stress regulation, sleep, and autonomic balance.
This is an important development because it represents a new neuromodulation pathway and may expand access to treatment. However, it is not intended to replace usual care or serve as a stand-alone cure for PTSD. Long-term, independent, and real-world research will help clarify who benefits most.
Neurofeedback
Neurofeedback gives a person information about patterns of brain activity and uses practice to help them develop greater self-regulation. Dr. Ruth Lanius and other researchers have studied neurofeedback for PTSD, including its potential effects on brain networks involved in self-processing, emotion regulation, and dissociation.
Early findings are encouraging, but neurofeedback protocols vary considerably. Questions remain about which brain signals should be trained, how many sessions are needed, how benefits transfer into everyday life, and whether one protocol is appropriate for different PTSD presentations. Neurofeedback should therefore be considered a developing treatment area rather than an established replacement for trauma-focused psychotherapy.
Virtual Reality and Digital Treatment
Virtual reality can recreate controlled environments for exposure-based treatment. It may be especially useful when a person has difficulty imagining or describing a traumatic environment or when realistic practice can help someone engage in therapy.
Dr. Barbara Rothbaum pioneered virtual-reality exposure for PTSD, particularly among combat veterans.
However, a recent VA evidence review found that virtual-reality Prolonged Exposure may offer little or no advantage over conventional Prolonged Exposure, and the overall evidence remains uncertain.
The value of VR may eventually be less about being a stronger treatment and more about increasing access, engagement, personalization, or the ability to practice particular situations safely.
Digital tools are also being developed to support:
Symptom monitoring
Sleep tracking
Between-session practice
Telehealth treatment
Wearable measures of arousal
Earlier identification of people at risk
Personalized treatment recommendations
Technology should support the therapeutic relationship and treatment plan—not substitute for appropriate assessment and care.
Psychedelic-Assisted Therapy and Neuroplastogens
MDMA, psilocybin, methylone, and other compounds are being studied for PTSD and related conditions. Some researchers use the term neuroplastogen for compounds that may temporarily increase the brain’s capacity for plastic change. The theory is that, when paired with structured psychotherapy, this period of increased plasticity may help a person approach traumatic material, reduce avoidance, develop new perspectives, and create different emotional associations.
Dr. Rachel Yehuda and the Parsons Research Center for Psychedelic Healing at Mount Sinai are among the leaders studying psychedelic-assisted approaches for trauma.
Research involving MDMA-assisted therapy has produced promising results, and the VA launched an additional clinical trial in 2026. Research into psilocybin and methylone is also progressing.
These treatments remain highly specialized and investigational. Increased research activity or an FDA decision allowing a trial to proceed does not mean a substance has been approved as a safe, effective PTSD treatment.
Clinical protocols involve screening, preparation, monitoring, psychotherapy, and integration. They should not be recreated through unsupervised use.
Intensive Treatment Programs
Innovation is not limited to devices and medications. Some programs now deliver evidence-based PTSD treatment several times per week or through a concentrated program lasting days or weeks.
The Emory Healthcare Veterans Program, led by Dr. Barbara Rothbaum and Dr. Sheila Rauch, uses an intensive two-week model for eligible post-9/11 veterans and service members.
Intensive treatment may help some people:
Complete therapy in a shorter period
Reduce the time spent anticipating the next session
Receive faster feedback and support
Coordinate multiple services
Step away from normal demands while participating in care
Intensive treatment is not appropriate or accessible for everyone, but it demonstrates that innovation can involve delivering proven care differently—not only inventing something new.
PTSD Is Not the Same in Every Brain
Some people with PTSD primarily experience hyperarousal: intense fear, vigilance, irritability, startle responses, and difficulty settling. Others experience dissociation: numbness, detachment, altered awareness, or feeling disconnected from the body or surroundings. Many experience both at different times.
Dr. Ruth Lanius’s work has helped define the dissociative subtype of PTSD and the importance of understanding brain-body differences among trauma survivors.
This matters because an intervention that helps someone safely approach fear may need to be delivered differently for a person who disconnects, becomes numb, or loses awareness under stress.
The future of PTSD treatment is likely to involve better matching among:
Trauma history
Symptom pattern
Coexisting conditions
Brain and physiological measures
Treatment preference
Access and support
Previous treatment response
Personalized care does not mean everyone needs an expensive scan or experimental procedure. It means providers should stop treating PTSD as though every person has the same nervous system, history, symptoms, and goals.
Veterans and Post-Traumatic Stress Injury
Veterans helped bring the PTSI framework into public conversation because the word injury recognizes that psychological harm may occur in the course of service—just as physical injury can.
Military trauma may involve:
Combat exposure
Blast injuries
Military sexual trauma
Moral injury
The death of fellow service members
Repeated exposure to life-threatening situations
TBI and PTSD occurring together
Difficulty transitioning from operational readiness to civilian life
On Veterans Day, honoring service should include recognizing injuries that cannot be seen.
Veterans with PTSD symptoms can ask:
Have I received a comprehensive PTSD assessment?
Could TBI, pain, sleep problems, hearing changes, depression, or substance use also be affecting my symptoms?
Which evidence-based PTSD treatments are available?
Do I qualify for an intensive treatment program?
Is telehealth available?
If standard treatment has not helped, would a consultation about neuromodulation or a clinical trial be appropriate?
Who is coordinating my care?
What support is available for my family or caregiver?
The VA National Center for PTSD provides treatment information, decision aids, mobile tools, and resources for veterans, families, and clinicians.
Researchers and Centers Shaping the Field
Several leaders represent different directions in contemporary PTSD research:
Dr. Frank Ochberg
Ochberg helped establish the PTSD diagnosis and became a leading advocate for the term post-traumatic stress injury. His work emphasizes dignity, reduced stigma, individualized treatment, and the expectation that an injured person can heal.
Dr. Kerry Ressler
At McLean Hospital and Harvard Medical School, Ressler studies fear learning, neural circuits, genomics, molecular biology, biomarkers, risk, and resilience. His work is helping move PTSD research toward more precise biological targets.
Dr. Rachel Yehuda
At Mount Sinai and the James J. Peters VA, Yehuda has led research into trauma biology, cortisol, epigenetics, intergenerational trauma, resilience, treatment response, and psychedelic-assisted therapy.
Dr. John Krystal
At Yale and the VA National Center for PTSD, Krystal leads research involving neurobiology, biomarkers, imaging, novel medications, and translational treatment development.
Dr. Paul Holtzheimer
At Dartmouth and the National Center for PTSD, Holtzheimer studies TMS, deep-brain stimulation, tDCS, vagus-nerve stimulation, and brain-imaging approaches for treatment-resistant psychiatric conditions.
Dr. Ruth Lanius
At Western University, Lanius studies PTSD neurobiology, dissociation, altered self-processing, brain-body disconnection, neurofeedback, and personalized trauma treatment.
Dr. Barbara Rothbaum and Dr. Sheila Rauch
At Emory University, Rothbaum and Rauch have advanced Prolonged Exposure, virtual-reality treatment, intensive PTSD programs, clinician training, and veteran care.
Precision-neuromodulation teams
Researchers including Dr. Sanne van Rooij, Dr. Tanja Jovanovic, Dr. Paul Holtzheimer, and their collaborators are investigating how imaging and individual brain connectivity might guide more precise stimulation targets.
These individuals and institutions represent areas to watch; their inclusion is not an endorsement of every theory, program, or commercial treatment connected to their work.
How to Evaluate a “Brain-Rewiring” PTSD Treatment
The language of neuroplasticity is powerful—and sometimes misused.
Before beginning a treatment, ask:
Is this an established treatment, an emerging option, or an experiment?
Is it recommended by current clinical guidelines?
Has it been studied specifically in people with PTSD?
Was it compared with a credible control or established treatment?
Did it improve daily functioning or only a brain scan or test score?
What risks and side effects were reported?
Who should not receive the treatment?
Is the provider licensed to treat PTSD?
Does the provider have specific trauma-treatment training?
How will progress be measured?
Will the provider coordinate with the rest of the care team?
What happens if symptoms worsen or the treatment does not help?
Is the cost supported by the quality of evidence?
Is the program promising a cure or guaranteed “reset”?
Be cautious when brain images, neuroscience terminology, or testimonials are used as substitutes for credible evidence.
A Different Way to Understand Recovery
Approaching PTSD as an injury changes the story. The person is not defective. Their brain and nervous system adapted to survive an experience that overwhelmed their ordinary capacity to cope. Those adaptations may have once been protective, even if they are now interfering with sleep, relationships, work, health, or a sense of safety.
Neuroplasticity means those patterns are not necessarily permanent.
Recovery may involve:
Fewer intrusive memories
Less avoidance
Improved sleep
Greater emotional regulation
A stronger sense of present safety
Renewed connection with other people
More confidence in the body
Returning to meaningful activities
Learning to remember without repeatedly reliving
The goal is not to pretend that the trauma never happened. It is to help the brain and body recognize that the event is no longer happening now.
NPA helps people affected by neurological and brain-based conditions understand treatment options, evaluate emerging approaches, advocate for their needs, and navigate a complicated healthcare system.
Visit Neuroplasticity Alliance to explore educational resources, programs, and treatment-navigation support.
This article is for educational and informational purposes only. It is not intended to provide medical advice, diagnosis, or treatment. PTSD requires evaluation by a qualified healthcare professional. If symptoms are severe, worsening, or creating an immediate safety concern, seek urgent professional assistance.
Comments